News

$65 million in funding resuscitates NeoRx

February 3, 2006/

The NeoRx of two years ago would hardly recognize itself today: new management, 40 percent fewer employees, a single cancer drug in development, and, this week, fresh money.

The Seattle company announced a $65 million infusion of private capital Wednesday, staving off insolvency and prolonging its life for another five years at its current spending rate.

By Benjamin J. Romano

Seattle Times business reporter

Full Story: http://seattletimes.nwsource.com/html/businesstechnology/2002780071_neorx03.html

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


"For small to medium to national organizations, for events and fundraisers of any size, in any format – live, virtual or hybrid – the platform is built for scale."

MATR Supporters (view all)


Working closely with GFDA’s economic development team, HPF helps Montana businesses access the capital they need to expand, modernize, and strengthen local communities.

The Great Falls Development Alliance delivers aggressive, award-winning economic development support for business attraction, expansion, and retention.

Make Your Future in the College of Business